Mark E. Tryniski, Director at CONMED CORP (CNMD), sold 13,480 shares at $120.88 ($1.6M) on 2021-02-16, disclosed to the SEC on 2021-02-18.
Open-market sale of $1.6M CNMD by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $120.69 | 217 | $26K | 1.6% |
| 2 | $120.69 | 229 | $28K | 1.7% |
| 3 | $120.69 | 273 | $33K | 2.0% |
| 4 | $120.69 | 329 | $40K | 2.4% |
| 5 | $120.69 | 462 | $56K | 3.4% |
| 6 | $120.88 | 2,230 |
| $270K |
| 16.5% |
| 7 | $120.88 | 2,230 | $270K | 16.5% |
| 8 | $121.31 | 2,545 | $309K | 18.9% |
| 9 | $121.31 | 2,545 | $309K | 18.9% |
| 10 | $122.10 | 2,420 | $295K | 18.1% |
| Total | $121.24 avg | 13,480 | $1.6M | 100% |
| Filing → |
| CNMD | SELL | 2021-11-08 | $3.9M | — | Filing → |
| CNMD | SELL | 2021-02-23 | $427K | — | Filing → |
| CBU | SELL | 2019-12-26 | $2.6M | — | Filing → |